Literature DB >> 1140620

Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects.

T C Northfield, N F LaRusso, A F Hofmann, J L Thistle.   

Abstract

Oral treatment with chenodeoxycholic acid causes dissolution of cholesterol gallstones in man. In order to determine the mechanism of this effect, we have measured 24-hour biliary lipid output, lipid composition of fasting gallbladder bile, and bile acid pool sizes before and during such treatment in six patients with radiolucent gallstones in functioning gallbladders. In all six patients, the degree of cholesterol saturation of fasting-state gallbladder bile was decreased during treatment to a level below the thermodynamic solubility line. This effect was due to a decrease in biliary cholesterol output, associated with conversion of more than 90% of the total bile acid pool to chenodeoxycholic acid. It could not be attributed to an increase in total bile acid pool size nor to an increase in biliary bile acid or phospholipid output.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1140620      PMCID: PMC1410946          DOI: 10.1136/gut.16.1.12

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

1.  Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones.

Authors:  J L Thistle; A F Hofmann
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

2.  Biliary lipid secretion in gallstone patients.

Authors:  T C Northfield; A F Hofmann
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

3.  Gallstone dissolution in man using chenodeoxycholic acid.

Authors:  G D Bell; B Whitney; R H Dowling
Journal:  Lancet       Date:  1972-12-09       Impact factor: 79.321

4.  Solubility of cholesterol in bile salt-lecithin model systems.

Authors:  N Tamesue; T Inoue; K Juniper
Journal:  Am J Dig Dis       Date:  1973-08

5.  Letter: A simple calculation of the lithogenic index of bile: expressing biliary lipid composition on rectangular coordinates.

Authors:  P J Thomas; A F Hofmann
Journal:  Gastroenterology       Date:  1973-10       Impact factor: 22.682

6.  Effect of bile acid feeding on cholesterol metabolism in gallstone patients.

Authors:  N E Hoffman; A F Hofmann; J L Thistle
Journal:  Mayo Clin Proc       Date:  1974-04       Impact factor: 7.616

7.  Cholesterol solubility in model bile systems: implications in cholelithiasis.

Authors:  D Mufson; K Triyanond; J E Zarembo; L J Ravin
Journal:  J Pharm Sci       Date:  1974-03       Impact factor: 3.534

8.  Proceedings: Mechanism of action of chenodeoxycholic acid in gallstone dissolution.

Authors:  T C Northfield; N F Larusso; J L Thistle; A F Hofmann
Journal:  Gut       Date:  1973-10       Impact factor: 23.059

9.  Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.

Authors:  R C Danzinger; A F Hofmann; J L Thistle; L J Schoenfield
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

10.  Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man.

Authors:  R T Holzbach; M Marsh; M Olszewski; K Holan
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

View more
  28 in total

1.  Chenodeoxycholic acid in the management of gall stones.

Authors:  R G Batey
Journal:  Drugs       Date:  1977-08       Impact factor: 9.546

2.  Kinetic analysis of biliary lipid excretion in man and dog.

Authors:  C I Wagner; B W Trotman; R D Soloway
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

Review 3.  Deoxycholic acid and the pathogenesis of gall stones.

Authors:  S N Marcus; K W Heaton
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

4.  The effects of 3,5,5-trimethylcyclohexanol on hepatic cholesterol synthesis, bile flow and biliary lipid secretion in the rat.

Authors:  G D Bell; R J Clegg; W R Ellis; B Middleton; D A White
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

5.  The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man.

Authors:  M C Carey; D M Small
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

6.  Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones.

Authors:  J H Iser; P N Maton; G M Murphy; R H Dowling
Journal:  Br Med J       Date:  1978-06-10

7.  Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.

Authors:  T J Meredith; G V Williams; P N Maton; G M Murphy; H M Saxton; R H Dowling
Journal:  Gut       Date:  1982-05       Impact factor: 23.059

8.  Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?

Authors:  J H Iser; G M Murphy; R H Dowling
Journal:  Gut       Date:  1977-01       Impact factor: 23.059

9.  Regulation of bile acid synthesis in man. Presence of a diurnal rhythm.

Authors:  W C Duane; D G Levitt; S M Mueller; J C Behrens
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

10.  Effect of ioglycamide (Biligram) on bile flow and biliary lipid secretion in man.

Authors:  G D Bell; J Doran; M Fayadh; G Murphy; R H Dowling
Journal:  Gut       Date:  1978-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.